Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer

Gastroenterology

Volumn 123, Issue 4, 2002, Pages 1031-1043

  Kita, Hiroto ^a   Naidenko, Olga V ^b   Kronenberg, Mitchell ^b   Ansari, Aftab A ^c   Rogers, Paul ^b   He, Xiao Song ^a   Koning, Frits ^d   Mikayama, Toshifumi ^b   Van de Water, Judy ^a   Coppel, Ross L ^e   Kaplan, Marshall ^f   Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LEIDEN UNIVERSITY   (Netherlands)

^e MONASH UNIVERSITY   (Australia)

^f TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GALACTOSYLCERAMIDE; T LYMPHOCYTE RECEPTOR;

ARTICLE; AUTOIMMUNE DISEASE; BACULOVIRUS EXPRESSION SYSTEM; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; NATURAL KILLER CELL; PHENOTYPE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0036787437     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.36020     Document Type: Article

References (48)

1. Bendelac A, Rivera MN, Park SH, Roark JH. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu Rev Immunol 1997;15:535-562.
2. Chen H, Paul WE. Cultured NK1.1+ CD4+ T cells produce large amounts of IL-4 and IFN-γ upon activation by anti-CD3 or CD1. J Immunol 1997;159:2240-2249.
3. Cui J, Shin T, Kawano T, Sato H, Kondo E, Toura I, Kaneko Y, Koseki H, Kanno M, Taniguchi M. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 1997;278: 1623-1626.
4. Pied S, Roland J, Louise A, Voegtle D, Soulard V, Mazier D, Cazenave PA. Liver CD4-CD8- NK1.1+ TCR α β intermediate cells increase during experimental malaria infection and are able to exhibit inhibitory activity against the parasite liver stage in vitro. J Immunol 2000;164:1463-1469.
5. − T cells differentiate extrathymically in a l ck-independent manner and participate in early response against Listeria monocytogenes infection through interferon-γ production. Immunology 1997;91:511-519.
6. Sumida T, Sakamoto A, Murata H, Makino Y, Takahashi H, Yoshida S, Nishioka K, Iwamoto I, Taniguchi M. Selective reduction of T cells bearing invariant V α 24J α Q antigen receptor in patients with systemic sclerosis. J Exp Med 1995;182:1163-1168.
7. Wilson SB, Kent SC, Patton KT, Orban T, Jackson RA, Exley M, Porcelli S, Schatz DA, Atkinson MA, Balk SP, Strominger JL, Hafler DA. Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes. Nature 1998;391:177-181.
8. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K, Ueno H, Nakagawa R, Sato H, Kondo E, Koseki H, Taniguchi M. CD1d-restricted and TCR-mediated activation of vα14 NKT cells by glycosylceramides. Science 1997;278:1626-1629.
9. Brossay L, Chioda M, Burdin N, Koezuka Y, Casorati G, Dellabona P, Kronenberg M, CD1d-mediated recognition of an α-galactosyl-ceramide by natural killer T cells is highly conserved through mammalian evolution. J Exp Med 1998;188:1521-1528.
10. Davodeau F, Peyrat MA, Necker A, Dominici R, Blanchard F, Leget C, Gaschet J, Costa P, Jacques Y, Godard A, Vie H, Poggi A, Romagne F, Bonneville M. Close phenotypic and functional similarities between human and murine alphabeta T cells expressing invariant TCR α-chains. J Immunol 1997;158:5603-5611.
11. − T cells. J Exp Med 1997;186:109-120.
12. Exley M, Porcelli S, Furman M, Garcia J, Balk S. CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant V α 24 J α Q T cell receptor α chains. J Exp Med 1998;188:867-876.
13. Prussin C, Foster B. TCR V α 24 and V β 11 coexpression defines a human NK1 T cell analog containing a unique Th0 subpopulation. J Immunol 1997;159:5862-5870.
14. Matsuda JL, Naidenko OV, Gapin L, Nakayama T, Taniguchi M, Wang CR, Koezuka Y, Kronenberg M. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers (see comments). J Exp Med 2000;192:741-754.
15. Benlagha K, Weiss A, Beavis A, Teyton L, Bendelac A. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J Exp Med 2000;191:1895-1903.
16. Coppel RL, Gershwin ME. Primary biliary cirrhosis: the molecule and the mimic. Immunol Rev 1995;144:17-49.
17. Tsuneyama K, Yasoshima M, Harada K, Hiramatsu K, Gershwin ME, Nakanuma Y. Increased CD1d expression on small bile duct epithelium and epithelioid granuloma in livers in primary biliary cirrhosis. Hepatology 1998;28:620-623.
18. Sakai T, Naidenko OV, Iijima H, Kronenberg M, Koezuka Y. Syntheses of biotinylated α-galactosylceramides and their effects on the immune system and CD1 molecules. J Med Chem 1999;42: 1836-1841.
19. Brodsky FM, Bodmer WF, Parham P. Characterization of a monoclonal anti-β 2-microglobulin antibody and its use in the genetic and biochemical analysis of major histocompatibility antigens. Eur J Immunol 1979;9:536-545.
20. Shimoda S, Van de Water J, Ansari A, Nakamura M, Ishibashi H, Coppel RL, Lake J, Keeffe EB, Roche TE, Gershwin ME. Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J Clin Invest 1998;102:1831-1840.
21. Matsuda JL, Gapin L, Fazilleau N, Warren K, Naidenko OV, Kronenberg M. Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor β repertoire and small clone size. Proc Natl Acad Sci U S A 2001;98:12636-12641.
22. Pannetier C, Even J, Kourilsky P. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today 1995;16:176-181.
23. Porcelli S, Yockey CE, Brenner MB, Balk SP. Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8-α/β T cells demonstrates preferential use of several V β genes and an invariant TCR α chain. J Exp Med 1993;178:1-16.
24. +-Iike thymocytes in the NOD mouse. Eur J Immunol 1996;26:2989-2998.
25. − thymocytes. J Autoimmun 1997;10:279-285.
26. − T-cell deficiency and IDDM in NOD/Lt mice. Diabetes 1997;46:572-582.
27. Godfrey DI, Hammond KJ, Poulton LD, Smyth MJ, Baxter AG, NKT cells: facts, functions and fallacies. Immunol Today 2000;21: 573-583.
28. + NKT cells associated with disease development in autoimmune-prone mice. J Immunol 1996;156: 4035-4040.
29. Takeda K, Dennert G. The development of autoimmunity in C57BL/6 Ipr mice correlates with the disappearance of natural killer type 1-positive cells: evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimmune symptoms. J Exp Med 1993;177: 155-164.
30. − (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J Exp Med 1998;187:1047-1056.
31. Lehuen A, Lantz O, Beaudoin L, Laloux V, Carnaud C, Bendelac A, Bach JF, Monteiro RC. Overexpression of natural killer T cells protects Vα14- Jα281 transgenic nonobese diabetic mice against diabetes. J Exp Med 1998;188:1831-1839.
32. Hong S, Wilson MT, Serizawa I, Wu L, Singh N, Naidenko OV, Miura T, Haba T, Scherer DC, Wei J, Kronenberg M, Koezuka Y, Van Kaer L. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat Med 2001;7:1052-1056.
33. Wang B, Geng YB, Wang CR. CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes. J Exp Med 2001;194:313-320.
34. Sharif S, Arreaza GA, Zucker P, Mi QS, Sondhi J, Naidenko OV, Kronenberg M, Koezuka Y, Delovitch TL, Gombert JM, Leite-DeMoraes M, Gouarin C, Zhu R, Hameg A, Nakayama T, Taniguchi M, Lepault F, Lehuen A, Bach JF, Herbelin A. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med 2001;7:1057-1062.
35. Miyamoto K, Miyake S, Yamamura T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 2001;413:531-534.
36. Zeng D, Lee MK, Tung J, Brendolan A, Strober S. Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB/NZW mice. J Immunol 2000;164:5000-5004.
37. Reinhardt C, Melms A. Elevated frequencies of natural killer T lymphocytes in myasthenia gravis. Neurology 1999;52:1485-1487.
38. Illes Z, Kondo T, Newcombe J, Oka N, Tabira T, Yamamura T. Differential expression of NK T cell V α 24J α Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. J Immunol 2000;164:4375-4381.
39. + NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin Immunol 2001;100:144-148.
40. +) T cells preferentially accumulate in human liver. Eur J Immunol 1999;29:2406-2413.
41. + NK cells in vitro. J Immunol 2000;165:1659-1664.
42. + natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. J Immunol 1999;163:2314-2321.
43. Takeda K, Hayakawa Y, Van Kaer L, Matsuda H, Yagita H, Okumura K. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci U S A 2000;97: 5498-5503.
44. Osman Y, Kawamura T, Naito T, Takeda K, Van Kaer L, Okumura K, Abo T. Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide. Eur J Immunol 2000;30:1919-1928.
45. Karadimitris A, Gadola S, Altamirano M, Brown D, Woolfson A, Klenerman P, Chen JL, Koezuka Y, Roberts IA, Price DA, Dusheiko G, Milstein C, Fersht A, Luzzatto L, Cerundolo V. Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography. Proc Natl Acad Sci U S A 2001;98:3294-3298.
46. + T cells and rapid elimination of effector cells by apoptosis. Eur J Immunol 1998; 28:3448-3455.
47. Yonekura K, Ichida T, Sato K, Yamagiwa S, Uchida M, Sugahara S, Ito S, Abo T, Asakura H. Liver-infiltrating CD56 positive T lymphocytes in hepatitis C virus infection. Liver 2000;20:357-365.
48. Eberl G, MacDonald HR. Rapid death and regeneration of NKT cells in anti-CD3ε- or IL-12-treated mice: a major role for bone marrow in NKT cell homeostasis. Immunity 1998;9:345-353.